Vericel Corp
XMUN:ATQP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vericel Corp
XMUN:ATQP
|
US |
|
T
|
Thales SA
LSE:0IW5
|
FR |
|
B
|
Brunswick Corp
XBER:BWI
|
US |
|
Sanofi SA
F:SNW
|
FR |
|
Equinor ASA
F:DNQA
|
NO |
|
C
|
China Citic Bank Corp Ltd
XMUN:D7C
|
CN |
Wall St Price Targets
ATQP Price Targets Summary
Vericel Corp
According to Wall Street analysts, the average 1-year price target for ATQP is 53.72 EUR with a low forecast of 48.3 EUR and a high forecast of 65.74 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ATQP's stock price target?
Price Target
53.72
EUR
According to Wall Street analysts, the average 1-year price target for ATQP is 53.72 EUR with a low forecast of 48.3 EUR and a high forecast of 65.74 EUR.
What is the Revenue forecast for Vericel Corp?
Projected CAGR
20%
The compound annual growth rate for Revenue over the next 7 years is 20%.
What is the Gross Profit forecast for Vericel Corp?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 3 years is 20%.
What is the Operating Income forecast for Vericel Corp?
Projected CAGR
63%
The compound annual growth rate for Operating Income over the next 7 years is 63%.
What is the Pre-Tax Income forecast for Vericel Corp?
Projected CAGR
73%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.
What is the Net Income forecast for Vericel Corp?
Projected CAGR
49%
The compound annual growth rate for Net Income over the next 7 years is 49%.
